Prosecution Insights
Last updated: October 26, 2026
Application No. 18/864,465

USE OF A POLYCARBOXYLATE COPOLYMER AND ALKYL ETHER SULFATE AS COMPATIBILIZER IN TANK MIX COMPOSITION

Non-Final OA §103§112
Filed
Nov 08, 2024
Priority
May 11, 2022 — nonprovisional of PCTEP2022062845
Examiner
SHIAO, REI TSANG
Art Unit
1629
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Speciality Operations France
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
1m
Est. Remaining
46%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
1656 granted / 2073 resolved
+19.9% vs TC avg
Minimal -34% lift
Without
With
+-33.5%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
49 currently pending
Career history
2124
Total Applications
across all art units

Statute-Specific Performance

§101
2.0%
-38.0% vs TC avg
§103
29.2%
-10.8% vs TC avg
§102
8.8%
-31.2% vs TC avg
§112
30.0%
-10.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 2073 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Priority and Status of the Claims 1. This application is a 371 of PCT/EP2022/0628845 05/11/2022. 2. Claims 1-18 and 20 are pending in the application. Claim Rejections - 35 USC § 112 3. The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. Claim 1-18 and 20 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112, first paragraph (pre-AIA ), because the specification does not reasonably provide enablement of the instant “dithiocarbamate fungicide”, “strobilurin”, “pyrazole- carboxamide fungicide”, “benzoylurea insecticide”, “neonicotinoid insecticide”, “pyrethroid insecticide”, “phenoxy herbicide”, “pyrimidinedione herbicide”, “sulfonylurea herbicide“, “cyclohexanedione herbicide “, and “benzoic acid herbicide” without limitation (i.e., no named compounds). The specification does not enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make the invention commensurate in scope with the claim. ln In re Wands, 8 USPQ2d 1400 (1988), factors to be considered in determining whether a disclosure meets the enablement requirement of 35 U.S.C. 112, first paragraph, have been described. They are: 1. the nature of the invention, 2. the state of the prior art, 3. the predictability or Iack thereof in the art, 4. the amount of direction or guidance present, 5. the presence or absence of working examples, 6. the breadth of the claims, 7. the quantity of experimentation needed, and 8. the level of the skill in the art. In the instant case: The nature of the invention The nature of the invention is a composition comprising “dithiocarbamate fungicide”, “strobilurin”, “pyrazole-carboxamide fungicide”, “benzoylurea insecticide”, “neonicotinoid insecticide”, “pyrethroid insecticide”, “phenoxy herbicide”, “pyrimidinedione herbicide”, “sulfonylurea herbicide“, “cyclohexanedione herbicide “, and “benzoic acid herbicide” without limitation (i.e., no named compounds), see claims 1-2, 7-16 and 20. The state of the prior art and the predictability or Iack thereof in the art The state of the prior art is Blasco et al. US 2008/0200334 A1, it discloses a number of fungicide including maneb, metam, metriram, and captan, see column 8. The amount of direction or guidance present and the presence or absence of working examples The only direction or guidance present in the instant specification is the exemplified a number of “dithiocarbamate fungicide”, “strobilurin”, “pyrazole-carboxamide fungicide”, “benzoylurea insecticide”, “neonicotinoid insecticide”, “pyrethroid insecticide”, “phenoxy herbicide”, “pyrimidinedione herbicide”, “sulfonylurea herbicide “, “cyclohexanedione herbicide “, and “benzoic acid herbicide” on pages 6-10 of the specification. There are no working examples present for “dithiocarbamate fungicide”, “strobilurin”, “pyrazole-carboxamide fungicide”, “benzoylurea insecticide”, “neonicotinoid insecticide”, “pyrethroid insecticide”, “phenoxy herbicide”, “pyrimidinedione herbicide”, “sulfonylurea herbicide“, “cyclohexanedione herbicide “, and “benzoic acid herbicide” without limitation (i.e., no named compounds) found in the specification. The breadth of the claims The breadth of the claims is the instant “dithiocarbamate fungicide”, “strobilurin”, “pyrazole-carboxamide fungicide”, “benzoylurea insecticide”, “neonicotinoid insecticide”, “pyrethroid insecticide”, “phenoxy herbicide”,“pyrimidinedione herbicide”, “sulfonylurea herbicide“, “cyclohexanedione herbicide “, and “benzoic acid herbicide” without limitation (i.e., no named compounds). The quantity of experimentation needed The quantity of experimentation needed is undue experimentation. One of skill in the art would need to determine what “dithiocarbamate fungicide”, “strobilurin”, “pyrazole-carboxamide fungicide”, “benzoylurea insecticide”, “neonicotinoid insecticide”, “pyrethroid insecticide”, “phenoxy herbicide”,“pyrimidinedione herbicide”, “sulfonylurea herbicide“, “cyclohexanedione herbicide “, and “benzoic acid herbicide” without limitation (i.e., no named compounds) would be prepared by the instant claim 1, if any. The Ievel of the skill in the art The Ievel of skill in the art is high. However, due to the unpredictability in the pharmaceutical art, it is noted that each embodiment of the invention is required to be individually assessed for physical characteristics to determine which “dithiocarbamate fungicide”, “strobilurin”, “pyrazole-carboxamide fungicide”, “benzoylurea insecticide”, “neonicotinoid insecticide”, “pyrethroid insecticide”, “phenoxy herbicide”, “pyrimidinedione herbicide”, “sulfonylurea herbicide“, “cyclohexanedione herbicide “, and “benzoic acid herbicide” are prepared. Thus, the specification fails to provide sufficient support of the broad scope of the compounds of the instant claims for the “dithiocarbamate fungicide”, “strobilurin”, “pyrazole-carboxamide fungicide”, “benzoylurea insecticide”, “neonicotinoid insecticide”, “pyrethroid insecticide”, “phenoxy herbicide”,“pyrimidinedione herbicide”, “sulfonylurea herbicide“, “cyclohexanedione herbicide “, and “benzoic acid herbicide” As a result necessitating one of skill to perform an exhaustive search for which “lipid-lowing drug”, can be prepared of the instant claims in order to practice the claimed invention. Thus, factors such as "sufficient working examples", "the level of skill in the art" and "predictability", etc. have been demonstrated to be sufficiently lacking in the instantly claimed compounds. In view of the breadth of the claim, the chemical nature of the invention, and the lack of working examples regarding the activity of the claimed compositions/compounds in regards to the “lipid-lowing drug” without limitation, one having ordinary skill in the art would have to undergo an undue amount of experimentation to use the invention commensurate in scope with the claims. Genentech lnc. v. Novo Nordisk A/S (CA FC) 42 USPQ2d 1001, states that “ a patent is not a hunting license. It is not a reward for search, but compensation for its successful conclusion'' and ''patent protection is granted in return for an enabling disclosure of an invention, not for vague intimations of general ideas that may or may not be workable''. Therefore, in view of the Wands factors and ln re Fisher (CCPA 1970) discussed above, to practice the claimed invention herein, a person of skill in the art would have to engage in undue experimentation, with no assurance of success. This rejection can be overcome by incorporation of the “dithiocarbamate fungicide”, “strobilurin”, “pyrazole-carboxamide fungicide”, “benzoylurea insecticide”, “neonicotinoid insecticide”, “pyrethroid insecticide”, “phenoxy herbicide”,“pyrimidinedione herbicide”, “sulfonylurea herbicide“, “cyclohexanedione herbicide “, and “benzoic acid herbicide” (i.e., claims 2, and 7-16) supported by specification into claims 1 and 20 respectively would obviate the rejection. 4. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 103 5. The following is a quotation of 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103(a) are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or non-obviousness. This application currently names joint inventors. In considering patentability of the claims under 35 U.S.C. 103(a), the examiner presumes that the subject matter of the various claims was commonly owned at the time any inventions covered therein were made absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and invention dates of each claim that was not commonly owned at the time a later invention was made in order for the examiner to consider the applicability of 35 U.S.C. 103(c) and potential 35 U.S.C. 102(f) or (g) prior art under 35 U.S.C. 103(a). Claims 1-18 are rejected under 35 U.S.C. 103(a) as being obvious over Blasco et al. US 2008/0200334 A1. Applicants claim an agricultural tank-mix composition, comprising: a) an agricultural active composition comprising at least two pesticides selected from dithiocarbamate fungicide, chlorothalonil, glyphosate, flumioxazine, strobilurin fungicide, pyrazole-carboxamide fungicide, benzoylurea insecticide, neonicotinoid insecticide, pyrethroid insecticide, phenoxy herbicide, pyrimidinedione herbicide, sulfonylurea herbicide, cyclohexanediones herbicide and benzoic acid herbicide, and b) a compatibilizer selected from a composition comprising a copolymer comprising units of diisobutylene and methacrylic anhydride or methacrylic acid and C10-C16 alkyl ether sulfate salt, wherein the copolymer is present in an amount of ranging from 0.1 to 5 wt.%, based on a total weight of the agricultural tank-mix composition, see claim1. Dependent claims 2-18 further limit the scope of compounds, i.e., specific compound of fungicides, insecticides and herbicides, copolymer, and their specific amounts. Determination of the scope and content of the prior art (MPEP §2141.01) Blasco et al. ‘334 disclose an agriculture composition comprising maneb, metam, metriram, and captan, and copolymer polymethacrylate or polybutenes, see columns 4 and 8. Determination of the difference between the prior art and the claims (MPEP §2141.02) The difference between instant claims and Blasco et al. ‘334 is that the instant claims are embraced within the scope of Blasco et al. ‘334. It is noted that the instant claims are silent the scope of fungicide, insecticides and herbicides. Finding of prima facie obviousness-rational and motivation (MPEP §2142-2143) One having ordinary skill in the art would find the claims 1-18 prima facie obvious because one would be motivated to employ compounds/ compositions of Blasco et al. ‘334 to obtain instant invention. The motivation to make the claimed compounds/composition derived from the known compounds/compositions of Blasco et al. ‘334 would possess similar activity to that which is claimed in the reference. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to REI TSANG SHIAO whose telephone number is (571)272-0707. The examiner can normally be reached on 8:30 am-5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Renee Claytor can be reached on 571-272-8394. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /REI TSANG SHIAO/ Rei-tsang Shiao, Ph.D.Primary Examiner, Art Unit 1691 August 13, 2026
Read full office action

Prosecution Timeline

Nov 08, 2024
Application Filed
Aug 17, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766194
CITRATE-CONTAINING COMPOSITION, PRODUCTION METHOD AND DRY METHOD THEREFOR, AND TABLET CONTAINING SAID COMPOSITION
3y 0m to grant Granted Oct 20, 2026
Patent 12759990
THC DERIVATIVES, ORAL DOSAGE FORMS COMPRISING SAME, USES THEREOF FOR TREATING DISEASES AND DISORDERS AND SYNTHESIS THEREOF
3y 5m to grant Granted Oct 13, 2026
Patent 12760060
ANDROGEN RECEPTOR MODULATORS
3y 1m to grant Granted Oct 13, 2026
Patent 12758513
CAPSAICIN DERIVATIVES IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
2y 10m to grant Granted Oct 13, 2026
Patent 12747241
COMPOUNDS FOR TARGETING DEGRADATION OF BRUTON'S TYROSINE KINASE
2y 11m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
46%
With Interview (-33.5%)
2y 1m (~1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 2073 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month